Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
aldeyra therapeutics已完成Reproxalap用於乾眼病的3期臨床試驗招募。
Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
aldeyra therapeutics已完成Reproxalap用於乾眼病的3期臨床試驗招募。
譯文內容由第三人軟體翻譯。